Cargando…
Editorial: Assessment and management of adverse drug reactions in oncology
Autores principales: | Tsai, Ping-Feng, Ma, Kevin Sheng-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374297/ https://www.ncbi.nlm.nih.gov/pubmed/37520142 http://dx.doi.org/10.3389/falgy.2023.1223078 |
Ejemplares similares
-
Editorial: Adverse Vaccine Reactions
por: Terreehorst, Ingrid
Publicado: (2022) -
Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
por: Batista-Duharte, Alexander, et al.
Publicado: (2023) -
Editorial: Diagnosis and management of allergy to chemotherapy and biologics
por: Madrigal-Burgaleta, Ricardo, et al.
Publicado: (2023) -
Editorial: Antibiotic allergy de-labelling and management
por: Roizen, Gigia, et al.
Publicado: (2023) -
Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents
por: Borrás Cuartero, Julián, et al.
Publicado: (2022)